Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

Cited In for PubMed (Select 11465523)

1.

Effect of Placebo Conditions on Polysomnographic Parameters in Primary Insomnia: A Meta-Analysis.

Winkler A, Rief W.

Sleep. 2015 Jun 1;38(6):925-31. doi: 10.5665/sleep.4742.

PMID:
25515108
2.

Effects of different doses of doxepin on passive avoidance learning in rats.

Gharzi M, Dolatabadi HR, Reisi P, Javanmard SH.

Adv Biomed Res. 2013 Jul 30;2:66. doi: 10.4103/2277-9175.115823. eCollection 2013.

3.
4.

Management of insomnia: update and new approaches.

Unbehaun T, Spiegelhalder K, Hirscher V, Riemann D.

Nat Sci Sleep. 2010 Jul 28;2:127-38. Print 2010.

5.

Psychiatric disorders and sleep.

Krystal AD.

Neurol Clin. 2012 Nov;30(4):1389-413. doi: 10.1016/j.ncl.2012.08.018. Review.

6.

Insomnia pharmacotherapy.

Roehrs T, Roth T.

Neurotherapeutics. 2012 Oct;9(4):728-38. doi: 10.1007/s13311-012-0148-3. Review.

7.

Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia.

Krystal AD, Lankford A, Durrence HH, Ludington E, Jochelson P, Rogowski R, Roth T.

Sleep. 2011 Oct 1;34(10):1433-42. doi: 10.5665/SLEEP.1294.

8.

Prevalence and factors associated with off-label antidepressant prescriptions for insomnia.

Lai LL, Tan MH, Lai YC.

Drug Healthc Patient Saf. 2011;3:27-36. doi: 10.2147/DHPS.S21079. Epub 2011 Jul 8.

9.

Sleep neurobiology from a clinical perspective.

EspaƱa RA, Scammell TE.

Sleep. 2011 Jul 1;34(7):845-58. doi: 10.5665/SLEEP.1112. Review.

10.

Dissection of the factors driving the placebo effect in hypnotic treatment of depressed insomniacs.

McCall WV, D'Agostino R Jr, Rosenquist PB, Kimball J, Boggs N, Lasater B, Blocker J.

Sleep Med. 2011 Jun;12(6):557-64. doi: 10.1016/j.sleep.2011.03.008. Epub 2011 May 20.

11.

Antidepressant and Antipsychotic Drugs.

Krystal AD.

Sleep Med Clin. 2010 Dec 1;5(4):571-589. No abstract available.

12.

Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.

Krystal AD, Durrence HH, Scharf M, Jochelson P, Rogowski R, Ludington E, Roth T.

Sleep. 2010 Nov;33(11):1553-61.

13.

Diagnosis and treatment of chronic insomnia.

Saddichha S.

Ann Indian Acad Neurol. 2010 Apr;13(2):94-102. doi: 10.4103/0972-2327.64628.

14.

Ramelteon: a novel hypnotic indicated for the treatment of insomnia.

Zammit GK.

Psychiatry (Edgmont). 2007 Sep;4(9):36-42.

15.

Healthcare use in adults with insomnia: a longitudinal study.

Hayward R, Jordan KP, Croft P.

Br J Gen Pract. 2010 May;60(574):334-40. doi: 10.3399/bjgp10X501822.

16.

Clinical guideline for the evaluation and management of chronic insomnia in adults.

Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M.

J Clin Sleep Med. 2008 Oct 15;4(5):487-504.

17.

Which symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy?

Dombrovski AY, Cyranowski JM, Mulsant BH, Houck PR, Buysse DJ, Andreescu C, Thase ME, Mallinger AG, Frank E.

Depress Anxiety. 2008;25(12):1060-6. doi: 10.1002/da.20467.

18.

Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia.

Roth T, Rogowski R, Hull S, Schwartz H, Koshorek G, Corser B, Seiden D, Lankford A.

Sleep. 2007 Nov;30(11):1555-61.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk